| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Angion Biomedica Corp (NASDAQ: ANGN)
ANGN Technical Analysis
5
| As on 31st May 2023 ANGN STOCK Price closed @ 0.98 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.63 & Strong Sell for SHORT-TERM with Stoploss of 2.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ANGNSTOCK Price
| Open | 1.11 | Change | Price | % |
| High | 1.12 | 1 Day | -0.01 | -1.01 |
| Low | 0.88 | 1 Week | 0.19 | 24.05 |
| Close | 0.98 | 1 Month | 0.17 | 20.99 |
| Volume | 313739 | 1 Year | -2.61 | -72.70 |
| 52 Week High 3.59 | 52 Week Low 0.48 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ANGN Daily Charts |
ANGN Intraday Charts |
Whats New @ Bazaartrend |
ANGN Free Analysis |
|
|
ANGN Important Levels Intraday
| RESISTANCE | 1.44 |
| RESISTANCE | 1.29 |
| RESISTANCE | 1.20 |
| RESISTANCE | 1.11 |
| SUPPORT | 0.85 |
| SUPPORT | 0.76 |
| SUPPORT | 0.67 |
| SUPPORT | 0.52 |
ANGN Forecast May 2024
| 4th UP Forecast | 3.04 |
| 3rd UP Forecast | 2.38 |
| 2nd UP Forecast | 1.97 |
| 1st UP Forecast | 1.56 |
| 1st DOWN Forecast | 0.4 |
| 2nd DOWN Forecast | -0.01 |
| 3rd DOWN Forecast | -0.42 |
| 4th DOWN Forecast | -1.08 |
ANGN Weekly Forecast
| 4th UP Forecast | 1.89 |
| 3rd UP Forecast | 1.60 |
| 2nd UP Forecast | 1.42 |
| 1st UP Forecast | 1.24 |
| 1st DOWN Forecast | 0.72 |
| 2nd DOWN Forecast | 0.54 |
| 3rd DOWN Forecast | 0.36 |
| 4th DOWN Forecast | 0.07 |
ANGN Forecast2024
| 4th UP Forecast | 7.18 |
| 3rd UP Forecast | 5.19 |
| 2nd UP Forecast | 3.96 |
| 1st UP Forecast | 2.73 |
| 1st DOWN Forecast | -0.77 |
| 2nd DOWN Forecast | -2 |
| 3rd DOWN Forecast | -3.23 |
| 4th DOWN Forecast | -5.22 |
Angion Biomedica Corp ( NASDAQ USA Symbol : ANGN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ANGN Business Profile
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3777, a hepatocyte growth factor mimetic for acute kidney injury, acute lung injury, acute respiratory distress syndrome, central nervous system injuries, and heart injuries. It also develops ANG-3070, a tyrosine kinase inhibitor and rho kinase 2 inhibitors for fibrotic diseases; and CYP11B2, an aldosterone synthase inhibitor for aldosterone-related fibrotic diseases. The company was incorporated in 1998 and is based in Uniondale, New York. Address: 51 Charles Lindbergh Boulevard, Uniondale, NY, United States, 11553
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service